Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy

被引：5

作者：

Kerckhove, Nicolas ^{[1
,2
,3
]}

Selvy, Marie ^{[1
]}

Lambert, Celine ^{[2
]}

Gonneau, Coralie ^{[1
]}

Feydel, Gabrielle ^{[2
]}

Petorin, Caroline ^{[4
]}

Vimal-Baguet, Agnes ^{[4
]}

Melnikov, Sergey ^{[5
]}

Kullab, Sharif ^{[6
]}

Hebbar, Mohamed ^{[7
]}

Bouche, Olivier ^{[8
]}

Slimano, Florian ^{[9
]}

Bourgeois, Vincent ^{[10
]}

Lebrun-Ly, Valerie ^{[11
]}

Thuillier, Frederic ^{[11
]}

Mazard, Thibault ^{[12
]}

Tavan, David ^{[13
]}

Benmammar, Kheir Eddine ^{[14
]}

Monange, Brigitte ^{[14
]}

Ramdani, Mohamed ^{[15
]}

Pere-Verge, Denis ^{[16
]}

Huet-Penz, Floriane ^{[17
]}

Bedjaoui, Ahmed ^{[18
]}

Genty, Florent ^{[19
]}

Leyronnas, Cecile ^{[20
]}

Busserolles, Jerome ^{[1
,3
]}

Trevis, Sophie ^{[21
]}

Pinon, Vincent ^{[21
]}

Pezet, Denis ^{[22
]}

Balayssac, David ^{[1
,2
]}

机构：

[1] Univ Clermont Auvergne, INSERM U1107 NEURO DOL, Clermont Ferrand, France

[2] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France

[3] Univ Clermont Auvergne, Inst Analgesia, Clermont Ferrand, France

[4] CHU Clermont Ferrand, Serv Oncol Digest, Clermont Ferrand, France

[5] Ctr Hosp St Flour, Serv Chirurg Gen & Viscerale, St Flour, France

[6] Ctr Hosp Moulins Yzeure, Serv Oncol, Moulins, France

[7] CHRU Lille, Serv Oncol, Lille, France

[8] Univ Reims, Serv Oncol Digest, CHU Reims, Reims, France

[9] Univ Reims, Serv Pharm, SFR CAP Sante, BioSpect,CHU Reims, Reims, France

[10] Ctr Hosp Boulogne Sur Mer, Serv Oncol Digest, Boulogne Sur Mer, France

[11] CHU Limoges, Serv Oncol, Limoges, France

[12] Univ Montpellier, INSERM, IRCM, ICM, Montpellier, France

[13] Infirmerie Protestante Lyon, Serv Gastroenterol, Caluire Et Cuire, France

[14] Ctr Hosp Emile Roux, Serv Oncol, Le Puy En Velay, France

[15] Ctr Hosp Beziers, Serv Gastroenterol, Beziers, France

[16] Ctr Hosp St Joseph St Luc, Serv Hepatogastroenterol, Lyon, France

[17] Ctr Hosp Alpes Leman, Serv Gastro Enterol, Contamine Sur Arve, France

[18] Ctr Hosp Intercommunal Hop Leman, Serv Gastroenterol, Thonon Les Bains, France

[19] Ctr Hosp Vichy, Serv Chirurg Digest & Viscerale, Vichy, France

[20] Grp Hosp Mutualiste Grenoble, Serv Oncol, Grenoble, France

[21] CHU Clermont Ferrand, Serv Pharm, Clermont Ferrand, France

[22] Univ Clermont Auvergne, CHU Clermont Ferrand, USC INRA 2018, INSERM,M2iSH, Clermont Ferrand, France

来源：

FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷

关键词：

chemotherapy-induced peripheral neuropathy; neuropathic pain; colorectal cancer; oxaliplatin; cluster analysis; NEUROTOXICITY; QUESTIONNAIRE; PREVENTION; GUIDELINES; RISK;

D O I：

10.3389/fphar.2021.744085

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was designed to explore the possibility that different clusters of patients may co-exist among a cohort of patients with oxaliplatin-related CIPN. Other objectives were to characterize these clusters considering CIPN severity, anxiety, depression, health-related quality of life (HRQOL), patients' characteristics and oxaliplatin treatments. Among the 96 patients analyzed, three clusters were identified (cluster 1: 52, cluster 2: 34, and cluster 3: 10 patients). Clusters were significantly different according to CIPN severity and the proportion of neuropathic pain (cluster 1: low, cluster 2: intermediate, and cluster 3: high). Anxiety, depressive disorders and HRQOL alteration were lower in cluster 1 in comparison to clusters 2 and 3, but not different between clusters 2 and 3. This study underlines that patients with CIPN are not a homogenous group, and that CIPN severity is associated with psychological distress and a decline of HRQOL. Further studies are needed to explore the relation between clusters and CIPN management.

引用

页数：10

共 50 条

[41] Management of chemotherapy-induced peripheral neuropathy
Stillman M.
Cata J.P.
Current Pain and Headache Reports, 2006, 10 (4) : 279 - 287
[42] Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601
Smith, E. M. L.
Pang, H.
Ye, C.
Cirrincione, C.
Fleishman, S.
Paskett, E. D.
Ahles, T.
Bressler, L. R.
Le-Lindqwister, N.
Fadul, C. E.
Loprinzi, C.
Shapiro, C. L.
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (02)
[43] Falls in persons with chemotherapy-induced peripheral neuropathy
Tofthagen, Cindy
Overcash, Janine
Kip, Kevin
SUPPORTIVE CARE IN CANCER, 2012, 20 (03) : 583 - 589
[44] Management of Chemotherapy-Induced Peripheral Neuropathy
Trivedi, Meghna S.
Hershman, Dawn L.
Crew, Katherine D.
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 4 - 10
[45] Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Mezzanotte, Jessica N.
Grimm, Michael
Shinde, Namrata, V
Nolan, Timiya
Worthen-Chaudhari, Lise
Williams, Nicole O.
Lustberg, Maryam B.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 29 - 42
[46] Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir
Coriat, Romain
Alexandre, Jerome
Nicco, Carole
Quinquis, Laurent
Benoit, Evelyne
Chereau, Christiane
Lemarechal, Herve
Mir, Olivier
Borderie, Didier
Treluyer, Jean-Marc
Weill, Bernard
Coste, Joel
Goldwasser, Francois
Batteux, Frederic
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (01): : 262 - 272
[47] Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort
Sreeram, Kalyan
Seaton, Randell
Greenwald, Mark K.
Kamgar, Mandana
Assad, Hadeel
Baird, Tara
Schwartz, Ann G.
Ruterbusch, Julie
Simon, Michael S.
CANCER CAUSES & CONTROL, 2023, 34 (05) : 459 - 468
[48] Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry
Bonhof, C. S.
Trompetter, H. R.
Vreugdenhil, G.
van de Poll-Franse, L., V
Mols, F.
SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 5933 - 5941
[49] Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer
Compton, Stephanie L. E.
Yang, Shengping
Madere, Joseph
Weltzien, Erin K.
Caan, Bette J.
Meyerhardt, Jeffrey A.
Schmitz, Kathryn H.
Brown, Justin C.
CANCER, 2024,
[50] Electroneurography in the evaluation of oxaliplatin-induced neuropathy in colorectal cancer patients
Zygulska, A. L.
Banach, M.
Krzemieniecki, K.
NEOPLASMA, 2016, 63 (04) : 617 - 622

← 1 2 3 4 5 →